Sanpower's SVP Says Dendreon Deal Is a Milestone

SunPower has acquired Dendreon, marking the first acquisition of innovative US products by a Chinese company. The deal, valued at $820 million, is part of SunPower's strategy to expand into healthcare. Despite paying a premium compared to Valiant's previous purchase, SunPower believes the price is justified due to Dendreon's turnaround and profitability. The acquisition aligns with SunPower's plans to launch products in China and other markets.

What were the financial forecasts for Dendreon after the turnaround?

Why does the speaker believe the price paid for Dendreon was fair?